Related Experiment Videos

Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy

J K Camoriano, P R Greipp, G K Bayer

The New England Journal of Medicine

|April 30, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up.

Blood cancer journal·2016

High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.

Heart (British Cardiac Society)·2014

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.

Leukemia·2012

Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study.

Leukemia·2012

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.

Leukemia·2011

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

Leukemia·2010

See all related articles